High sensitivity C-reactive protein level in various manifestations of tuberculosis in children

  • Radita Kusumaningrum
  • Moh Syarofil Anam Diponegoro University
  • Dwi Wastoro Dadiyanto
  • Maria Mexitalia
  • Magdalena Sidhartani
Keywords: high sensitivity C-reactive protein, tuberculosis, children


Background Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. Of all TB patients, 40-50% are children. C-reactive protein (CRP) is produced during the inflammation process and is an indicator of active TB disease. High sensitivity CRP (hs-CRP) test has higher accuracy and sensitivity to detect CRP at lower levels.

Objective To compare hs-CRP in children with TB infection, pulmonary TB, and extra-pulmonary TB.

Methods This cross-sectional study of children with tuberculosis was conducted at Dr. Kariadi Hospital and the Semarang Community Health Center, Semarang, Central Java, from January 2020–February 2021. Inclusion criteria were patients aged 1–18 years with suspected TB (contact with adult TB patient or clinically suspected to have TB).

Results From 95 study subjects, 19 had TB infection, 51 had pulmonary TB, and 25 had extra-pulmonary TB. There was a significant increase in hs-CRP level based on prolonged fever (P<0.001), enlarged lymph glands (P=0.004), joint swelling (P=0.006), low WHZ or BMI for age (P=0.048), positive bacteriological evidence (P<0.001), and negative/not done tuberculin skin test (P=0.001). There was a significant difference of hs-CRP level based on TB status, with the highest hs-CRP level in extra-pulmonary TB [14.3 mg/l (0.16–321.5)], followed by pulmonary TB [0.8 mg/l (0.3–129.1)], and TB infection [0.7 mg/l (0.3–20.2)]. The highest hs-CRP level for extra-pulmonary TB was found in abdominal TB [84.5 mg/l (0.6–321.5)].

Conclusion  Children with extra-pulmonary TB have significantly higher hs-CRP than children with TB infection or pulmonary TB.


1. Kementerian Kesehataan RI Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Petunjuk teknis manajemen dan tatalaksana TB anak. Jakarta: Kementerian Kesehatan RI; 2016. p. 3-18.
2. WHO. Global tuberculosis report 2017. France: World Health Organization; 2017. p.1-3, 172.3. DOI: WHO/HTM/TB/2017.23.
3. WHO. Global tuberculosis report 2018. France: World Health Organization; 2018. p.1, 44, 188.
4. WHO. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018. p. 5.
5. Cruz AT, Starke JR. Pediatric tuberculosis. Pediatr Rev. 2010;31:13-25. DOI: 10.1542/pir.31-1-13.
6. Yoon C, Chaisson LH, Patel SM, Allen IE, Drain PK, Wilson D, et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2017;21:1013-9. DOI: 10.5588/ijtld.17.0078.
7. Brown J, Clark K, Smith C, Hopwood J, Lynard O, Toolan M, et al. Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis. BMC Infect Dis. 2016;16:1-8. DOI: 10.1186/s12879-016-1612-1.
8. Kandukuri E, Sarma DVHS, Sushma P, Moulali D, Naaz A. Serum MDA (malondialdehyde), hs-CRP and adenosine deaminase levels in pulmonary tuberculosis patient’s. Int J Sci Res Publ. 2015;5:1-3.
9. Rao VS, Murthy KVVS. High-sensitivity C-reactive protein?? Is it significant in tuberculous spondylitis? Int J Sci Study. 2016;3:274-9. DOI: 10.17354/ijss/2016/164.
10. Saraswati LD, Ginandjar P, Widjanarko B, Puspitasari RA. Epidemiology of child tuberculosis (a cross-sectional study at Pulmonary Health Center Semarang City, Indonesia). IOP Conf Ser Earth Environ Sci. 2018;116:1-9. DOI: 10.1088/1755-1315/116/1/012081.
11. Thomas TA. Tuberculosis in children. Pediatr Clin North Am. 2017;64:893-909. DOI:10.1001/jama.2016.0287.
12. Marais BJ. Childhood intra-thoracic tuberculosis. Adv Exp Med Biol. 2009;634:129-46. DOI: 10.1007/978-0-387-79838-7_12.
13. Jaganath D, Mupere E. Childhood tuberculosis and malnutrition. J Infect Dis. 2012;206:1809-15. DOI: 10.1093/infdis/jis608.
14. Devrim I, Aktürk H, Bayram N, Apa H, Tulumoglu S, Devrim F, et al. Differences between pediatric extra-pulmonary and pulmonary tuberculosis: a warning sign for the future. Mediterr J Hematol Infect Dis. 2014;6:1-6. DOI: 10.4084/mjhid.2014.058.
15. Kashyap B, Gupta N, Dewan P, Hyanki P, Singh NP. High sensitivity C reactive protein: an adjunct diagnosis in ruling out pediatric tuberculosis. Indian J Clin Biochem. 2020;35:211-7. DOI: 10.1007/s12291-018-0806-2.
16. Sharma RK, Sharma R, Sharma N, Sandhu R, Sharma A, Mahajan C, et al. Study of the serum levels of C-reactive proteins as an indicator of disease activity in pulmonary tuberculosis and monitoring response to treatment. Ann Int Med Dent Res. 2016;2:23-7. DOI: 10.21276/aimdr.2016.2.6.ME6.
17. Roya-Pabon CL, Perez-Velez CM. Tuberculosis exposure, infection and disease in children: a systematic diagnostic approach. Pneumonia. 2016;8:1-18. DOI:0.1186/s41479-016-0023-9.
18. Khuder HS, Norrei A, Khuder Y. High sensitive C-reactive protein in patients with pulmonary tuberculosis in Tikrit City. IJAPBC. 2013;2:611-5.
19. Ciccacci F, Welu B, Ndoi H, Karea I, Orlando S, Brambilla D, et al. High-sensitivity C-reactive protein in HIV care: tuberculosis diagnosis and short-term mortality in a cohort of Kenyan HIV patients in the DREAM programme. Int J Infect Dis. 2021;104:329-34. DOI: 10.1016/j.ijid.2021.01.008.
20. Aygun D, Akcakaya N, Cokugras H, Camc?oglu Y. Evaluation of clinical and laboratory characteristics of children with pulmonary and extrapulmonary tuberculosis. Medicina. 2019;55:1-9. DOI: 10.3390/medicina55080428.
How to Cite
Kusumaningrum R, Anam M, Dadiyanto D, Mexitalia M, Sidhartani M. High sensitivity C-reactive protein level in various manifestations of tuberculosis in children. PI [Internet]. 20Sep.2021 [cited 29Sep.2023];61(5):253-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2625
Pediatric Respirology
Received 2021-03-16
Accepted 2021-09-20
Published 2021-09-20